Skip to content

Use of Individualized Homoeopathic medicines and Glycyrrhiza glabra mother tincture in the treatment of Hyperlipidemia

A Synopsis On Effectiveness Of Individualized Homoeopathic Medicines And Glycyrrhiza Glabra Mother Tincture In The Treatment Of Hyperlipidemia: An Open Randomized Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/043957
Enrollment
60
Registered
2022-07-13
Start date
Unknown
Completion date
Unknown
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

Intervention1: Individualized Homoeopathic medicine: Intervention will be planned as administering indicated homoeopathic medicines selected on the basis of homoepathic principles in centesimal potenc

Sponsors

National Institute of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a) Patients of both sexes and all religions. b)Patients with Body Mass Index (BMI): For females 25â??30 and For males 26â??30. c) Patients already undergoing to regular therapy for hyperlipidemia, provided the medication are stopped completely at least 2 weeks prior study entry. d) Patients giving written consent to participate in the study.

Exclusion criteria

Exclusion criteria: a) Patients of age group below 30 and above 70 years. b) Patients with BMI: Females, BMIâ?? Males, BMIâ?? c) Patients who will be too sick for consultation. d) Patients of diagnosed cases of systemic diseases, unstable mental or psychiatric illness or other uncontrolled or life threatening illness affecting quality of life or any organ failure, pregnancy and lactation, substance abuse and/or dependence, self reported immunocompromised state, and patients availing homeopathic treatment for chronic disease within last 6 months. e) Patients unwilling to take part or not giving consent to participate in the study.

Design outcomes

Primary

MeasureTime frame
It will be done using Serum lipid profile according to NCEP desirable cholesterol level as: Total Cholesterol - 200mg/dl. LDL Cholesterol - 130 mg/dl. HDL Cholesterol - 50 mg/dl. Triglycerides - 200 mg/dl. Timepoint: At the baseline, 3rd month, and at 6th month

Secondary

MeasureTime frame
It will be done by assessing quality of life of patients on the basis of score obtained from COOP/WONCA Functional Assessment Chart. It measures six core aspects of functional status: Physical fitness, Feelings, Daily activities, Social activities, Change in health and Overall health. Each item is rated on this five-point ordinal scale ranging from 5 (â??no limitation at allâ??) to 5 (â??severely limitedâ??).Timepoint: At the baseline, 3rd month, and at 6th month

Countries

India

Contacts

Public ContactDr Chintamani Nayak

National Institute Of Homoeopathy

drcnayak@gmail.com9433161854

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026